Aflibercept

FDA to Approve Eylea’s Breakthrough Dose for Diabetic Eye Disease

Regeneron’s High-Dose Eylea Demonstrates Persistence as FDA Decision Looms

SG Tylor

While awaiting an FDA decision regarding a higher-dose version of Eylea (aflibercept), Regeneron has consistently emphasized the durability of their ...